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Abstract 
Background: Lead is a known endocrine disruptor and can impair regulation of blood glucose, 
blood pressure, abdominal adiposity, blood lipid levels which are risk factors for metabolic 
syndrome (MetS). 
Objective: To study the association of lead exposure and MetS in United States (U.S.) adults. 
Methods: Data from 523 male and 528 female participants aged 20 years and older from the 
2013 to 2014 National Health and Nutrition Examination Survey (NHANES) were analyzed. 
Based on blood lead distribution in males and females, participants were categorized into low 
and high blood lead groups in both genders. Adjusted logistic regression analysis was used to 
determine association between lead exposure and MetS; controlling for age, ethnicity, income 
and smoking status. 
Results: The overall median blood lead levels for U.S. adults aged 20 years and older were 1.03 
ug/dL; median blood lead levels were higher for males (1.23ug/dL) and lower for females (0.86 
ug/dL). Prevalence of MetS in the male and female was 57.55% and 38.60%, respectively. 
Compared to low blood lead groups, neither men nor women in high blood lead group showed 
any elevated risk of MetS. The adjusted odds ratio (95% confidence interval) of MetS in males 
was 0.741 (0.464-1.20), p-value: 0.209, in females it was 0.921 (0.563-1.51), p-value: 0.745. 
Conclusion: For adults aged 20 years and older low median blood lead levels in the U.S. were 
not significantly associated with MetS. 
 Keywords: metabolic syndrome, NHANES, blood lead levels, public health 
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Lead Exposure and Metabolic Syndrome in U.S. Population, NHANES 2013-2014 
Lead is a blue-gray metal that naturally occurs in all parts of our environment and is 
found in small quantities in the earth’s crust (Shukla, Shukla, & Tiwari, 2018). Most of the lead 
exposure seen today comes from human activities. Although the majority of these activities have 
been either banned or restricted the burning of fossil fuels, mining and manufacturing have been 
known leading contributors (Obeng-Gyasi, 2018). 
Common sources of lead include household paint, petrol, industrial emissions, canning 
and drinking water (Obeng-Gyasi, 2018). Government regulations has since restricted or limited 
the usage or emission of lead as a means to curb the environmental and human burden of lead 
exposure. The fate of inhaled or ingested lead or lead particles depends on several factors. The 
bloodstream is the primary repository for absorbed lead and distributes lead through the body, 
allowing for further absorption by other tissues (Centers for Disease Control and Prevention 
[CDC], 2017). Lead is primarily housed in the blood, mineralized tissue (the bones and teeth) 
and soft tissue (CDC, 2018). The amount of lead absorbed is dependent upon the route of 
exposure. Small particles of lead found in dust can result in a higher absorption levels than lead 
that may be ingested (CDC, 2017). 
 Lead is found in both organic and inorganic compounds (CDC, 2017). Organic lead 
compounds, the type of lead found in petrol and used as additives, are metabolized in the liver 
(Moon, 2013); whereas inorganic lead is not metabolized by the liver. In an adult human the 
half-life of lead within the blood is estimated to be between 28 to 36 days (CDC, 2018). 
Exposure to lead is measured using Blood Lead Levels (BLL) (CDC, 2017). It has been 
estimated that 94% of the total lead body burden of adults is located in the bones and teeth 
(CDC, 2017). Lead in mineralizing tissues are not distributed equally, lead accumulates in bones 
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that are undergoing the most calcification at the time of exposure (CDC, 2017). Since lead is 
stored in the bones symptoms of lead exposure can be present without significant current 
exposure (CDC, 2018). Most instances of toxic BLL are from a mixture of current and previous 
lead exposures (CDC, 2017). However, acute high rates of exposure can cause high short term 
BLL’s and symptoms of lead poisoning (CDC, 2018). 
Lead exposure continues to be a public health issue. As a heavy metal and an endocrine 
disruptor, lead is associated with adverse human cardio metabolic outcomes such as high blood 
pressure, increased Body Mass Index and high cholesterol (Grundy, Brewer, Cleeman, Smith, & 
Lenfant, 2004). Metabolic syndrome (MetS) is a clustering of risk factors that predispose the 
body to the development of cardiovascular disease (CVD) (Huang, 2009). Lead has been linked 
with higher prevalence of MetS in Korean population (Rhee et al., 2013). The five components 
that contribute to MetS are high blood pressure, high blood glucose levels, a larger waist 
circumference, high blood lipid levels and lastly low high-density lipoproteins (HDL). The 
presence of any three of these five components is considered MetS (Grundy et al., 2004). The 
prevalence of MetS in the United States (U.S.) is estimated to be 33% (Aguilar, Bhuket, Torres, 
Liu, & Wong, 2015), while the worldwide prevalence of MetS is estimated to be 25% (Nolan, 
Carrick-Ranson, Stinear, Readings, & Dalleck, 2017). However, in the U.S. MetS prevalence in 
regard to lead has not been explored in the general adult population. The present study aimed to 
examine this question using data from National Health and Nutrition Examination Survey 
(NHANES) 2013 to 2014.  
Research Question 
 What effect does exposure to lead have on the development of MetS among the U.S. 
population? It has been documented that lead is an endocrine disruptor and that disruption of the 
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endocrine system has the potential to lead to MetS. Therefore, we hypothesize that there will be a 
positive association between blood lead levels and MetS.    
Literature Review 
Lead Exposure 
Lead is a naturally occurring metal in the environment which has been known to have 
irreversible and toxic effects on the body. Mineral deposits within the Earth’s crust are a primary 
source of the toxic heavy metal (Shukla et al., 2018). Lead is a persist heavy metal that can linger 
in the environment, leaving populations to be potentially exposed in areas where lead may have 
been previously deposited. 
Exposure to lead can affect nearly all of the systems within the human body (CDC, 
2018). Lead exposure can occur with no obvious signs and symptoms. In fact, lead has two 
characteristics which are of great concern; it does not have a detectible taste or smell causing it 
to frequently appear unrecognized until exposure related damage has occurred (Shukla et al., 
2018). Before U.S. policy changes primary sources of lead exposure were from petrol, industrial 
emissions, household paint, food canning processing and drinking water. It was a widely held 
belief that the lead content in petrol would improve the performance of engines in automobiles 
(Obeng-Gyasi, 2018). This led to the respiratory absorption of lead from automobile emissions. 
Once the harmful effects of breathing in lead from automobile emissions was recognized, new 
government regulations enacted in the 1970’s pushed for the removal of lead from petrol 
(Perron, Hartt, McCann, McGowan, & Segers, 2018). Also, in this era the government regulated 
the output of industrial facilities in the hopes of decreasing environmental exposures of lead 
(Perron et al., 2018). Paints containing lead where banned in 1978, while domestic food 
processors voluntarily removed lead seals from their cans in the early 1990’s (Shukla et al., 
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2018). Drinking water can be another source of lead exposure. Water can be contaminated at its 
source by the environment or by pipes that are used to transport water, either because they are 
made of lead or use lead components (Brochin et al., 2011). 
There is no safe level of lead exposure, and even low levels can have an effect on one’s 
health. The World Health Organization recommends that adults should have a blood lead 
concentration below 10 μg/dL (CDC, 2018). The National Institute for Occupational Safety and 
Health (NIOSH) also recommends that BLL for adults should be less than 10μg/dL, with adults 
defined as those age sixteen years and older (CDC, 2018). 
Absorption, Metabolism and Excretion  
Absorption of lead can occur via the gastrointestinal tract by digestion through 
contaminated foods, food preparation or storage containers or by lead particles on hands. 
Inhalation of lead particles in dust is a pathway for lead to enter the body through the respiratory 
system. Once absorbed by the body it can be stored in the soft tissues and bones (Leech, Adams, 
Weathers, Staten, & Filippelli, 2016). BLL increases once exposure has occurred; however, 
within one month these levels decrease as the lead is deposited into the bones. More than 90% of 
the total bodily lead content is housed in the bones of the body where the half-life can be decades 
long (Leech et al., 2016). Excretion of lead is through the hair, sweat and nails; the primary 
excretion method however is in the urinary system. 
Lead Health Effects 
Lead exposure primarily affects the nervous system in both adults and in children; 
however, in adult populations increased BLL is associated with cardiovascular disease, 
hypertension, decreased renal function, increase in waist-to-hip ratio, and elevated blood lipid 
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levels (Moon, 2013). The diseases and conditions associated with increased BLL’s are closely 
tied to the endocrine function of the human body. 
Impact of Lead on Endocrine Function 
 Bodily functions are controlled by a network of glands throughout the body, the 
endocrine system. Two of the most important glands to the endocrine system are the 
hypothalamus and the pituitary gland. The hypothalamus is responsible for maintaining the 
stability of the internal environment, homeostasis. It is here that the nervous system and the 
endocrine system are connected via the pituitary gland. The function of the pituitary gland is to 
secrete hormones that release or inhibit hormones for bodily function (Brochin et al., 2011).  
Some of the bodily functions controlled by hormones of the pituitary gland include: regulating 
metabolism, triggering the release of cortisol (stress hormone), tissues of the liver, protein 
synthesis, elevation of blood glucose levels, and maintenance of blood pressure (Brochin et al., 
2011). 
The most detrimental effects of lead exposure are seen in the nervous system, where lead 
blocks receptors in the brain that would naturally communicate to maintain normal bodily 
functions (Brochin et al., 2011). The toxicity of lead disrupts the communication of the receptor 
cells and crosses the blood-brain barrier (Brochin et al., 2011). Maintenance of the fluid 
environment of the nervous system is one of the very important functions of the blood-brain 
barrier. Unlike other organs in the body that transport molecules by simple diffusion, the blood-
brain barrier only uses certain essential molecules that are water-soluble to be transported by 
carriers in the plasma membrane (Brochin et al., 2011). Exposure of high levels of lead causes 
plasma to move into interstitial spaces of the brain causing edema (Brochin et al., 2011). 
LEAD EXPOSURE AND METABOLIC SYNDROM 9 
The central nervous system and hormonal changes govern hunger, satiety, sleep patterns which 
can impact metabolic functions such as blood glucose levels, blood pressure, and eating habits 
that lead to increased waist circumference and blood lipid levels. These are all individual 
components of the endocrine disorder metabolic syndrome (Huang, 2009). Exposure to lead 
affects these individual components by way of the endocrine system. Increased blood glucose 
levels have been associated with lead exposure; it is thought that chronic exposure to lead 
inhibits the metabolism of glucose and lipids (Leff, Stemmer, Tyrrell, & Jog, 2018). In addition, 
a study that examined exposure of heavy metals on human pancreatic function concluded that an 
adverse correlation exists between heavy metal exposure and pancreatic function (Leff et al., 
2018). This evidence suggests that lead exposure can impact endocrine function of the pancreas 
(Leff et al., 2018).  
 Effects on blood pressure. As previously discussed lead affect parts of the central 
nervous system that regulates blood pressure levels. In addition, it has been hypothesized that the 
damaging effects of lead on renal function is the primary cause of hypertension in those exposed 
to lead (Gambelunghe et al., 2016). Other studies have concluded that lead inhibits the 
compliance of vascular smooth muscles to contract and dilate in the cardiovascular system 
essentially inhibiting the control of blood pressure (Kristal-Boneh, Coller, Froom, Harari, & 
Ribak, 1999). In either instance the effects of lead exposure on the body’s ability to self-regulate 
blood pressure have been explored and documented.  
 Effects on obesity. Lead exposure is also associated with obesity. The association of 
obesity with increased waist circumference has also been well documented. Alterations in the 
function of the hypothalamic-pituitary hormones have been linked with obesity (Delavari, 
Forouzanfar, Akikhani, Sharifian, & Kelishadi, 2009). In particular, lead exposure inhibits the 
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release of growth hormones (Brochin et al., 2011) and increases insulin release, both of which 
are linked to obesity (Delavari et al., 2009).  
 Effects on blood lipid levels. Lastly, blood lipid levels are another component of 
metabolic syndrome that is impacted by exposure of lead on the endocrine system. It 
hypothesized in the Kristal-Boneh, Coller, Froom, Harari, and Ribak (1999) study that the 
release of enzymes needed to metabolize lipids in the bloodstream are impeded by exposure to 
lead, thus causing the lipid levels to accumulate and remain within the body. Growth hormone 
deficiencies are also associated with increased total cholesterol and decreased HDL cholesterol 
levels; as previous discussed lead is an inhibitor of growth hormones release (Kristal-Boneh et 
al., 1999).  
Evidence suggests that the delicate functioning of the endocrine system can easily be 
disturbed by the exposure of heavy metals such as lead. The previously discussed metabolic 
functions are governed by the endocrine system. However, with the disturbed homeostasis of the 
endocrine system, disorders such as metabolic syndrome can develop. 
Metabolic Syndrome 
 MetS is a grouping of risk factors associated with the development of atherosclerotic 
cardiovascular disease. It is comprised of five components: elevated blood pressure, elevated 
blood glucose levels, a larger waist circumference, elevated blood lipid levels and low HDL 
(Huang, 2009). Defining criteria for MetS as developed by the National Cholesterol Education 
Program (NCEP) Adult Treatment Plan (ATP) III in 2001 for adult populations and is 
summarized in Table 1 (Akbaraly et al., 2010). Based on the definitions by the American Heart 
Association and the National Heart, Lung, and Blood Institute diagnosis of MetS is diagnosed 
when a patient has three of the five conditions noted in Table 1 from NCEP ATP III (Grundy et 
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al., 2004). Since it is known that the disruption of the endocrine systems has the potential to lead 
to MetS, we will examine whether lead exposure can be associated with the development of 
MetS. 
Table 1 
NCEP ATP III Criteria for Metabolic Syndrome* 
Risk Factor       Defining Criteria 
Blood Pressure      > 130 systolic/> 85 diastolic mmHg 
Blood Glucose Level      > 100 mg/dL 
Blood Triglycerides Level     > 150 mg/dL 
HDL Cholesterol 
 Men       < 40 mg/dL 
 Women      < 50 mg/dL 
Waist Circumference   
 Men       > 102 cm (> 40 in) 
 Women      > 88 cm (>35 in) 
*According to the National Cholesterol Education Program (NCEP) Adult Treatment Plan III. Copied verbatim from 
Grundy, Brewer, Cleeman, Smith, & Lenfant, 2004, p. 3. 
 
Methods 
Data Source and Study Design 
 Data were obtained from the 2013 to 2014 NHANES population-based survey. The 
survey collects health and nutritional information about noninstitutionalized U.S. individuals 
every two years. The purpose of the survey is to collect a representative sample of the U.S. 
population. All consent documents, brochures, and operational manuals for the 2013 to 2014 
dataset are available online, at the NHANES website that is part of the CDC. 
 In the 2013 to 2014 survey cycle a total of 14,332 persons were selected from 30 
different survey locations. From those selected 10,175 completed the interview and 9,813 were 
examined. Participants were examined at a mobile examination center (MEC), where physical 
assessments, laboratory measurements and examinations were conducted. Testing of serum 
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samples were conducted by the CDC’s Division of Laboratory Sciences of National Center for 
Environmental Health (CDC, 2015). 
 From the 2013 to 2014 dataset, individuals with available blood lead samples and data for 
the five components of MetS (waist circumference, blood pressure, glucose, triglycerides and 
HDL) were included in the analysis. The final sample size was N = 5,215. 
Cofounders 
 Socioeconomic and sociodemographic information (i.e., age, race/ethnicity, gender, 
smoking status and income) were collected as part of the NHANES Family Questionnaire by the 
Computer-Assisted Personal interview (CAPI) system. Race/ethnicity was reported as Hispanic, 
non-Hispanic White, non-Hispanic Black, and other multi-racial; with Hispanic as the referent 
group. Income was reported as <$25000, $25000-$54999, and >$55000; <$25000 was the 
referent group. Smoking status was determined by utilizing the serum cotinine levels in blood 
samples that were obtained at the MEC. Categories for smoking status were broken down into 
‘Never’, ‘Ex-smoker’, and ‘Current smoker’. The never smoked category is the referent group.  
Laboratory Procedures and Examination 
 All measurements were taken at a MEC (CDC, 2015). Waist circumference, weight and 
height were measured by trained health professionals. A retractable steel measuring tape was 
used for waist circumference measurements in centimeters (cm), a digital scale was used for 
weight in kilograms (kg) and a stadiometer was used for height measurements in meters (m).  
 Blood pressure measurements (systolic and diastolic) were also taken at a MEC. Three 
consecutive readings were taken from the right arm of the participant; the left arm was only used 
if there was a problem with the right arm. If a participant has any issues with both arms (casts, 
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paralysis, rashes, edema, open sores, any dressings, wounds and/or if the cuff does not fit) the 
participants were excused from this part of the examination (CDC, 2015). 
 Fasting glucose, triglycerides and HDL levels were tested on all participants samples, 
with the blood samples were collected at the MEC and sent to the testing labs (CDC, 2015). 
Metabolic Syndrome Determination 
 Clinical criteria determinations for MetS are listed in Table 1. The criteria are based on 
the NCEP Adult Treatment Plan (ATP) III (Akbaraly et al., 2010). A diagnosis of MetS is made 
if a subject has at least three of the five criteria outlined in Table 1 (Grundy et al., 2004). Male 
and female participants are characterized as having MetS when they met the recommended 
gender specific criteria in Table 1. 
Statistical Analysis 
 Data analyses were conducted using the Statistical Package for Social Science (SPSS). 
Descriptive statistics for continuous variables were generated for the overall sample population 
and at the median value for both genders. This includes measures of centrality and dispersion. 
Frequency distributions were computed for all categorical variables (smoking, income, 
race/ethnicity) and MetS criteria (waist circumference, blood pressure, triglycerides, HDL, and 
blood glucose levels). 
To test statistical significance for continuous variable across gender, a 2-tailed t-test at an 
α=0.05 level of significance was used. The testing of statistical significance for categorical 
variables across gender utilized a chi-square test. BLL was dichotomized at the median into a 
low exposure group (<1.23 ug/dL) and high exposure group (≥1.23 ug/dL) for males and a low 
exposure group (<0.86 ug/dL) and high exposure group (≥0.86 ug/dL) for females. 
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An unadjusted logistic regression was conducted to assess the odds ratio (OR), 95% 
confidence interval (CI) and p-value of MetS with high exposure to BLL. A bivariate adjusted 
logistic regression model was built-up beginning with first regressing the effect of high BLL on 
MetS. In the next step, one variable was introduced at a time and the OR, 95% CI and p-value for 
the effect on BLL was reported. In the subsequent steps this variable was removed and another 
one was introduced to test its impact on BLL and MetS. 
Finally, a multivariable logistic regression was carried out for MetS, with MetS being the 
outcome or dependent variable. Covariates included age, income levels, race/ethnicity and 
smoking status.  
Results 
Descriptive Statistics 
 The sample for this study included 1,061 participants aged 20 and older. Table 2 
illustrates the demographic profile of the sample by gender and by amount of lead exposure. The 
median BLL for adults aged 20 years and older was 1.03 ug/dL; with males (1.23ug/dL) having a 
higher median BLL than females (0.86 ug/dL). The mean ages for males and females are similar; 
males 49.6 years of age and females 48.8 years of age. Race distribution was predominately non-
Hispanic Whites, with 45.30% of males and 46.80% of females identifying as non-Hispanic 
White. The predominant income was >$55000 (high income) with 37.50% in males and 37.90% 
in females. As for smoking 22.20% were current smokers in males. In the female sample 17.60% 
were current smokers. BMI distribution was comparable, both males and females were within the 
overweight category, mean values for males were 28.13 and 29.68 for females. 
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Table 2 
Characteristics of 2013-2014 NHANES Adult Participants and Metabolic Factors by Gender 
 
 
Note: NHW, Non-Hispanic White; NHB, Non-Hispanic Black; BMI, Body Mass Index; BP, Blood Pressure; TG, Triglycerides; FBG, Fasting Blood Glucose; WC, Waist 
Circumference; HDL, High Density Lipoproteins 
*Waist circumference and high density lipoproteins cutoff values for males 
†Waist circumference and high density lipoproteins cutoff values for females 
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Amongst the males 57.5% had MetS, while only 38.6% of females had MetS. 
Furthermore, 78.5% of the females who had low exposure to lead met the MetS criteria for blood 
pressure, whereas 81.7% of the females who had high exposure met the criteria. In addition, 
females met the MetS criteria for larger waist circumference and low HDL levels; 68.6% and 
69.5% respectively when compared to males. 
Logistic Regression Analysis 
Bivariate logistic regression results. As illustrated in Table 3 males with high exposure 
to BLL did not have a significant association with MetS, neither in the unadjusted nor the 
bivariate adjusted models. For females, in the unadjusted models high BLL was associated with 
55% increased risk of MetS, OR=1.55 (1.08-2.20), p = .015. However, when adjusted for all 
other risk, high BLL in females was not associated with MetS.   
Table 3 
Bivariate Adjusted Odds Ratio (OR) and 95% Confidence Interval for Blood Lead Levels and 
Risk Factors of Metabolic Syndrome in Males and Females 
 
Male 
 
Female 
 
Characteristics 
Adjusted OR (95% 
CI) p-Value 
Adjusted OR (95% 
CI) p-value 
Blood Lead 0.815 (0.576-1.15) 0.249 1.55 (1.08-2.20) 0.015 
Age 0.599 (0.409-0.877) 0.008 0.758 (0.498-1.15) 0.196 
Race/Ethnicity 0.593 (0.404-0.869) 0.007 0.742 (0.487-1.13) 0.167 
Annual Income 0.524 (0.349-0.786) 0.002 0.727 (0.472-1.12) 0.148 
Smoking Status 0.537 (0.354-0.825) 0.003 0.672 (0.430-1.05) 0.082 
BMI 0.741 (0.464-1.18) 0.209 0.921 (0.563-1.51) 0.745 
Note: CI, Confidence Interval; BMI, Body Mass Index 
 
Multivariable logistic regression results. After adjusting for all risk factors in the 
multivariable model illustrated in Table 4, neither men nor women had any increased risk for 
MetS in the high blood lead group compared to the low blood lead group.  
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Table 4 
Multivariable Adjusted Odds Ratio (OR) for Blood Lead Levels and Risk Factors of Metabolic 
Syndrome 
      Males     Females 
Characteristic 
Adjusted OR 
(95%CI) p-value 
Adjusted OR 
(95%CI) p-value 
Blood Lead (ug/dL) 0.741 (0.464-1.20) 0.209 0.921 (0.563-1.51) 0.745 
Age in years 1.03 (1.01-1.04) 0.001 1.06 (1.041-1.08) 0.001 
Race/Ethnicity  
    NHW vs. Hispanic/others 0.751 (0.466-1.21) 0.239 0.715 (0.431-1.19) 0.194 
NHB vs. Hispanic/others 0.635 (0.343-1.20) 0.166 0.688 (0.360-1.32) 0.253 
Annual Income 
    $25000-$54999 vs. 
<$25000 0.717 (0.420-1.23) 0.246 1.97 (1.13-3.46) 0.018 
$55000+ vs. <$25000 0.562 (0.331-0.954) 0.035 1.56 (0.906-2.68) 0.109 
Smoking 
    Ex vs. Never 1.422 (0.853-2.40) 0.204 1.59 (0.853-2.99) 0.143 
Current vs. Never 1.345 (0.746-2.243) 0.423 1.95 (1.05-3.62) 0.035 
BMI (kg/m**2) 1.240 (1.174-1.300) 0.001 1.16 (1.12-1.20) 0.001 
Note: CI, Confidence Interval; NHW, Non-Hispanic White; NHB, Non-Hispanic Black; BMI, Body Mass Index 
 
A one-unit increase in age and BMI was associated with 3% and 24% greater odds of 
MetS in males and were statistically significant. In race/ethnicity, non-Hispanic Whites and non-
Hispanic Blacks when compared to Hispanic/others had a protective factor for MetS although 
this not statistically significant. For annual income both categories had a protective factor, with 
high income vs. low income reaching statistical significance.  
In females, a one unit increase in age and BMI showed 6% and 16% respectively greater 
odds of MetS and were statistically significant [OR=1.06, 95% CI=1.04-1.08, p = .001 and 
OR=1.16, 95% CI=1.12-1.20, p = .001]. Greater odds of MetS were also shown in middle 
income vs. low income category, as well as the current vs. never smoking category [OR=1.97,  
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95% CI= 1.13-3.46 and OR=1.95, 95% CI= 1.05-3.62]. Both odds were statistically significant 
with p = .018 and p = .035 respectively. 
Discussion 
In this cross-sectional analysis of the NHANES 2013 to 2014 data, blood lead was not 
associated with MetS in U.S. adult males and females aged 20 years older in adjusted models. 
Although in the unadjusted analysis, females had 55% significantly higher risk of MetS within 
the high mean blood lead groups as compared to the low group, this association was not 
significant once we adjusted for confounders. 
Earlier studies have shown a positive association between lead exposure and 
hypertension (Gambelunghe et al., 2016), waist circumference (Delavari et al., 2009) and blood 
lipid levels (Kristal-Boneh et al., 1999). The study on lead exposure by Kristal-Boneh et al., 
(1999) was based on occupational lead exposure (high exposure) which is not generalizable to 
the U.S. general population exposure that currently has very low mean blood lead levels (0.76 
ug/dL in males). In contrast to our study a Korean study reported significant association between 
blood lead and MetS, however their blood lead levels were 2.08 ug/dL, which is significantly 
higher than the blood lead levels reported for the sample in the present study (Moon, 2013). 
The prevalence of MetS in our studied population which is representative of the U.S. 
population was nearly 58%. Based on published reports the prevalence of MetS in the U.S. adult 
population has been increasing over the years as evidenced by the rising rates of MetS in 
NHANES datasets 2003 to 2004 (32.9%) compared to 2011 to 2012 (34.7%) (Aguilar et al,. 
2015). The highest MetS prevalence of 2014 where 38.6% for Hispanics, 37.4% for non-
Hispanic Whites, and over 50% in women and Hispanics older than 60 years of age (Aguilar et 
al., 2015). In other international studies it has been reported that there is an increasing magnitude 
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of MetS prevalence. The overall MetS prevalence in adults over the age of 45 had a prevalence 
above 50% (Delavari et al., 2009); which concurs with other studies, suggesting that the 
worldwide prevalence is on the rise. 
Strengths 
Strengths in this study include the usage of information from NHANES which is a 
nationally representative dataset and characterizing both genders and multiple ethnicities. Due to 
rigorous NHANES methodology bias is limited, the national survey uses intensive training that 
helps with prevention of selection and interview bias and uses state of the art laboratory 
facilities. This study is high in internal validity; we adjusted for a number of confounding 
variables including age, annual income, race/ethnicity and smoking status. Since NHANES is an 
excellent representation of the general population it has external validity. 
Limitations 
Limitations of this study include the cross-sectional nature of the NHANES data which 
does not allow studying temporality, one of the criteria for causality. The sample size for males 
and females was a little over 500 participants for each. In future studies a larger sample size 
could possibly be used by combining data from different survey cycles. Future areas of study 
could look at the impact of lead exposure in those younger than 20 years of age, as chronic 
diseases have been on the rise in children and adolescents. 
Conclusion 
 Based on the results of our study, lead exposure in U.S. adults aged 20 years and older 
does not have a statistically significant association with the prevalence of MetS in both males 
and females. Further analysis and identification of factors that contribute to the lack of 
significance will need additional evaluation.  
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Appendix A: Human Subjects Regulations Decision Chart 
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Appendix B: List of Competencies Met in Integrative Learning Experience 
CEPH Foundational Competencies Checklist 
Evidence-based Approaches to Public Health 
2. Select quantitative and qualitative data collection methods appropriate for a given public health context 
3. Analyze quantitative and qualitative data using biostatistics, informatics, computer-based programming and 
software, as appropriate 
4. Interpret results of data analysis for public health research, policy or practice 
Communication 
19. Communicate audience-appropriate public health content, both in writing and through oral presentation 
 
Concentration Specific Competencies Checklist 
Population Health Concentration 
2. Demonstrate application of an advanced quantitative or qualitative research methodology. 
3. Demonstrate the ability to contextualize and integrate knowledge of specific population health issues. 
 
